Shuai Wu

8PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersMolecular targetsGenome structure and regulationMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2026
Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance.

|Jul 14, 2025
Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer.

Hao Nie, Liping Liao, Rafal J Zielinski

|Sep 22, 2021
Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers.

Joseph A Zundell, Takeshi Fukumoto, Jianhuang Lin

|Sep 08, 2021
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer.

Jianhuang Lin, Heng Liu, Takeshi Fukumoto

|Jun 04, 2021
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma.

Shuai Wu, Takeshi Fukumoto, Jianhuang Lin

|Jul 18, 2019
HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer.

Takeshi Fukumoto, Nail Fatkhutdinov, Joseph A Zundell

Pageof 2

Frequent Collaborators

9 joint publications

Rugang Zhang

3 joint publications

Hsin-Yao Tang

3 joint publications

Qin Liu

3 joint publications

Jianhuang Lin